Skip to main content

Table 2 Clinical presentation and follow-up of 83 university students with acute pharyngitis

From: Throat and nasal swabs for molecular detection of respiratory viruses in acute pharyngitis

 

Virus only

Streptococcal ± virusc

 

E/Ra

Flu

Corona-virusa

Otherb

Negatives

No. patients at presentationa

19

8

9

5

20

23

Symptom duration, median no. of days (IQR)

3 (1)

3 (0)

3 (1)

3 (0)

2 (2)

2 (1)

Symptoms, n (%)

      

 Sore throatd

19 (100)

8 (100)

9 (100)

5 (100)

20 (100)

23 (100)

 Cough

16 (84)

8 (100)

7 (78)

4 (80)

13 (65)

15 (65)

 Fever

12 (63)

8 (100)

3 (33)

5 (100)

18 (90)

9 (39)

 Sneezing

14 (74)

6 (75)

7 (78)

4 (80)

7 (35)

7 (30)

 Runny nose

18 (95)

8 (100)

7 (78)

4 (80)

13 (65)

12 (52)

 Headache

13 (68)

7 (88)

5 (56)

5 (100)

14 (70)

13 (57)

 Sinus pain/pressure

12 (63)

7 (88)

5 (56)

3 (60)

10 (50)

8 (35)

 Cervical lymphadenopathy

10 (53)

6 (75)

3 (33)

3 (60)

15 (75)

13 (57)

No. (%) prescribed antibiotic

3 (16)

0 (0)

1 (11)

1 (20)

15 (75)

8 (35)

No. patients at one-week follow-up

19

7

9

6

19

21

Symptom duration, median no. of days (IQR)

4 (4)

4 (2)

7 (3)

4 (2)

3 (3)

7 (3)

No. (%) who missed ≥ 1 day of school

5 (26)

5 (71)

4 (44)

3 (50)

13 (68)

6 (29)

  1. Abbreviations: E/R Enterovirus/rhinovirus, IQR Interquartile range
  2. aOne patient with co-infection of rhinovirus and coronavirus HKU1 was analyzed in both columns
  3. bIncludes patients with adenovirus (n = 1), metapneumovirus (n = 2) and respiratory syncytial virus (n = 2)
  4. cIncludes patients with group A (n = 17) and group C (n = 3) beta-hemolytic streptococci, with five and three viral co-infections, respectively. No group G beta-hemolytic streptococci were detected
  5. dBy definition, this proportion is 100 % given study inclusion criteria